Morphine-Like Synthetic Pain Killer Lacks Side Effects

Details of their research were published in the May 23, 2011, online edition of the journal Nature Chemistry.

"This was a classic problem in chemical synthesis," said Dr. Glenn Micalizio, associate professor in of chemistry at the Scripps Research Institute, "which we were able to solve effectively and efficiently--an achievement that made subsequent assessment of the potential therapeutic properties of this rare natural product possible."

The synthetic conolidine was tested in a mouse model of tonic and persistent pain. Results showed that the new synthetic compound suppressed acute pain and inflammatory-derived pain, two key measures of efficacy. The new compound passed easily through the blood-brain barrier, and was present in the brain and blood at relatively high concentrations up to four hours after injection.

"Pharmacological studies confirmed that while it is not an opiate, it is nearly as potent as morphine," said Dr. Micalizio.

Related Links:
Scripps Research Institute